cardiac hypertrophy_Tg(Myh6-Gnaq*Q209L)52Ejne/?

http://metadb.riken.jp/0001625IFVBTgMyh6GnaqQ209L52EjneTgMyh6GnaqQ209L52Ejne

cardiac hypertrophy_Tg(Myh6-Gnaq*Q209L)52Ejne/?

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 52, E J Neer
  http://metadb.riken.jp/db/mgi_rdf/MGI:5559164

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Myh6-Gnaq*Q209L)52Ejne/?

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Myh6-Gnaq*Q209L)52Ejne

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: FVB

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• cardiac hypertrophy
  http://purl.obolibrary.org/obo/MP_0001625

文献

http://purl.org/net/cito/citesAsAuthority

• U. Mende, et.al., Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways., Proceedings of the National Academy of Sciences of the United States of America, 1998, 95
  http://rdf.ncbi.nlm.nih.gov/pubmed/9811897